MFLUIDX
Zika Virus, Dengue Fever, and other global pandemics ravish countries as a result of a lack of rapidly deployable field based diagnostics. mFluidX has created a DNA diagnostic test the size of a stick of gum that can be deployed and provide results in thirty minutes. All with a self-powered disposable chip that costs 1000x less than current bulky benchtop based lab diagnostics.
MFLUIDX
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.mfluidx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business PostalAddress Schema LocalBusiness Schema Wix
Current Employees Featured
![]()

Founder
![]()
![]()
Investors List
SkyDeck Berkeley
SkyDeck Berkeley investment in Non Equity Assistance - mFluiDx
IndieBio
IndieBio investment in Seed Round - mFluiDx
SOSV
SOSV investment in Seed Round - mFluiDx
Official Site Inspections
http://www.mfluidx.com Semrush global rank: 4.57 M Semrush visits lastest month: 905
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147

More informations about "mFluiDx"
Point-of-care | United States | MFluiDx
MFluiDx is developing a point-of-care molecular test - the โSIMPLE CHIPโ that achieves cost parity with rapid antigen tests while delivering PCR equivalent results with multiple pathogens tested at the same time.See details»
mFluiDx - Crunchbase Company Profile & Funding
MFluiDx focuses on the development of technology solutions to diagnose pandemics and offers a DNA diagnostic test. View contacts for mFluiDx to access new leads and connect with decision-makers.See details»
MFluidX Company Profile 2024: Valuation, Funding & Investors
Developer of microfluidic chips designed for the treatment of infectious diseases. The company's chips are based on microfluidics and use highly sensitive nucleic acid amplification targeting โฆSee details»
mFluiDx - LinkedIn
MFluiDx is a UC Berkeley spinout startup that develops innovative technology to enable rapid, low-cost molecular DNA/RNA diagnostics at point-of-care.See details»
mFluiDx, Inc. Company Profile | Oakland, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for mFluiDx, Inc. of Oakland, CA. Get the latest business insights from Dun & Bradstreet.See details»
mFluiDx, Inc. - VentureRadar
Website: http://mfluidx.com/ Develops a low-cost, quick turnaround molecular test called 'SIMPLE CHIP', capable of detecting multiple infectious agents, suitable for decentralized medical โฆSee details»
mFluiDx - Funding, Financials, Valuation & Investors - Crunchbase
Mar 1, 2020ย ยท mFluiDx focuses on the development of technology solutions to diagnose pandemics and offers a DNA diagnostic test.See details»
mFluidX - Products, Competitors, Financials, Employees, โฆ
MFluidX specializes in point-of-care molecular diagnostics within the healthcare sector. The company offers a product known as the SIMPLE CHIP, which provides cost-effective, rapid, โฆSee details»
mFluiDx Company Profile - Office Locations, Competitors, Revenue ...
MFluiDx is a company that provides point-of-care molecular diagnostics solutions for infectious disease diagnostics. It develops vacuum-based microfluidic chips to achieve DNA level โฆSee details»
mFluiDx | Intellectual Property & Industry Research Alliances
MFluiDx is a UC Berkeley startup developing Gates Foundation funded low-cost microfluidic diagnostic technologies capable of on-site multi-target isothermal DNA detection of infectious โฆSee details»
mFluiDx - Overview, News & Similar companies | ZoomInfo.com
MFluiDx contact info: Phone number: (510) 326-8816 Website: www.mfluidx.com What does mFluiDx do? mFluiDx selected as one of the top 20 startups to pitch at Techcrunch Battlefield, โฆSee details»
mFluiDx - CITRIS Foundry
MFluidx creates a highly sensitive, low cost, portable point-of-care microfludic diagnostic for DNA/RNA testing of infectious diseases. The company is based on UC Berkeley technology โฆSee details»
mFluiDx - Company Profile - Tracxn
Nov 16, 2024ย ยท mFluiDx - Microfluidic chips for infectious disease diagnostics. Raised a total funding of $250K over 1 round from 9 investors. Founded by Charlie Yeh and Danica Helb in โฆSee details»
mFluiDx - Crunchbase
MFluiDx focuses on the development of technology solutions to diagnose pandemics and offers a DNA diagnostic test.See details»
MICROFLUIDIC DIAGNOSTICS CORPORATION/mFluiDx - Taiwan โฆ
MFluiDx is aiming to develop the worldโs lowest cost, automated point-of-care DNA diagnostic assay for small clinics.See details»
mFluiDx - Contacts, Employees, Board Members, Advisors & Alumni
MFluiDx has 2 current employee profiles, including CEO and Co-Founder Charlie Yeh. mFluiDx focuses on the development of technology solutions to diagnose pandemics and offers a DNA โฆSee details»
mFluiDx - TechCrunch
MFluiDx focuses on the development of technology solutions to diagnose pandemics and offers a DNA diagnostic test. The Zika outbreak continues to worry the world, yet diagnosing the virus, โฆSee details»
Startup mFluiDx Developing Integrated Microfluidic for Point-of โฆ
Apr 3, 2017ย ยท NEW YORK (GenomeWeb) โ Startup mFluiDx โ a portmanteau of "microfluidics" and "diagnostics" โ is developing an inexpensive, sample-to-answer, self-digitizing โฆSee details»
mFluiDx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
MFluiDx focuses on the development of technology solutions to diagnose pandemics and offers a DNA diagnostic test.See details»
MFLUIDX Revenue, Growth & Competitor Profile - incfact.com
Compare how recession-proof Mfluidx is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the โฆSee details»